Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Male

Explore clinical trials studying Genital Diseases, Male. Study availability and eligibility vary by location and protocol.

25 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Male trial results

Recruiting

Study of HLD-0915 in Patients With Metastatic Prostate Cancer

NCT06800313

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +12 more
Locations
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale - New Haven Hospital - Yale Cancer Center New Haven, Connecticut, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

NCT06190899

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +12 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Centre Jean Perrin Clermont-Ferrand, France
  • Institut Paoli-Calmettes Marseille, France
  • Centre Antoine Lacassagne Nice, France
View all 13 locations
View Trial Details
Recruiting

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

NCT06496581

Conditions
Genital Diseases, Genital Diseases, Male, Male Urogenital Diseases, +3 more
Locations
  • Institut de Cancérologie de l'Ouest Angers, France
  • Institut Bergonié Bordeaux, France
  • CHRU Brest Brest, France
  • Centre Francois Baclesse Caen, France
View all 25 locations
View Trial Details
Completed

A JNJ-56021927 (ARN-509; Apalutamide) QT/QTc Study

NCT02578797

Conditions
Castration-resistant Prostate Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Greenville, South Carolina, United States
  • Montreal, Quebec, Canada
  • Chisinau, Moldova
  • Rotterdam, Netherlands
View Trial Details

Related conditions